Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.6748
+0.0127 (1.92%)
At close: Aug 13, 2025, 4:00 PM
0.6433
-0.0315 (-4.67%)
Pre-market: Aug 14, 2025, 9:16 AM EDT
Moleculin Biotech Employees
Moleculin Biotech had 17 employees as of December 31, 2024. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,561,765
Market Cap
20.38M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MBRX News
- 1 day ago - Moleculin Reports Second Quarter 2025 Financial Results and Highlights - GlobeNewsWire
- 8 days ago - Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment - GlobeNewsWire
- 15 days ago - Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin - GlobeNewsWire
- 23 days ago - Moleculin Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference - GlobeNewsWire
- 4 weeks ago - Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships - GlobeNewsWire
- 5 weeks ago - Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans - GlobeNewsWire
- 7 weeks ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 7 weeks ago - Moleculin Announces $5.9 Million Public Offering - GlobeNewsWire